JUNE 6, 2019 in This Month's Insights on IP, We Share with You Three

JUNE 6, 2019

In this month's Insights on IP, we share with you three recent articles that cover a compelling range of topics:

Intellectual Property is the new oil that fuels economic growth; however, countries such as the UK continue to overlook the power of IP; The recent $110 million purchase of Sports Illustrated by Authentic Brands for the publication's 60 years worth of valuable intangible assets including content, photography and magazine covers; Patent protection for stem cells, given the global market for stem cell therapies is expected to grow to $5b by 2024.

As always, if you would like to learn more about how Quantius lends to companies rich in intangible assets, please contact me directly.

Regards,

Len Kofman Chief Credit Oﬃcer Quantius Inc. Email: [email protected] Mobile: 647.234.1247 Intellectual Property - the New Oil that Fuels Economic Growth

"Famously in the late 1980s, Mark Getty coined the phrase that intellectual property was the oil of the 21st century. That is certainly true today as IP generates huge wealth and sets some developed economies way ahead of others.

The billionaires of the 21st century such as Bill Gates and Steve Wozniak have made their money from their IP. You only have to look at the Forbes list of top brands to see what that IP is worth and contributes to the economy. So why is IP so often overlooked in the UK?"

Click here to read the full article.

Sports Illustrated Sold to Authentic Brands for $110 Million

"Marketing and brand development company Authentic Brands Group has purchased the intellectual property of Sports Illustrated from Meredith Corporation for $110 million, the companies announced Monday night. The sale is not a traditional exchange of assets but instead creates an unusual partnership to steward the country’s most iconic legacy sports magazine.

Meredith will continue to print the magazine and manage the editorial side of Sports Illustrated for at least two years as part of the deal, people with knowledge of the agreement told The Washington Post, while Authentic Brands will license the magazine’s brand and all of its content."

Click here to read the full article.

Patent Protection for Stem Cells - Expanding Opportunities "Therapeutic applications of stem cells are central to the promise of regenerative medicine. An increasing number of stem cell therapies are being approved for clinical use and by some estimates the global market is expected to grow to ~5 billion dollars by 2024. However, commercializing any therapeutic application is diﬃcult. Careful consideration of patent strategy at the outset of R&D is critical for establishing a competitive advantage."

Click here to read the full article.

Want to change how you receive these emails? You can update your preferences or unsubscribe from this list.

This communication is confidential and for authorized use only. Under no circumstances are its contents to be reproduced or distributed to the public, media, or potential investors without written authorization. The information contained herein, while obtained from sources believed to be reliable, is not guaranteed as to its accuracy or completeness. The information contained in this communication is not investment or financial product advice and is not intended to be used as the basis for making an investment decision. This commentary by Quantius is not, and does not constitute, an offer to sell or the solicitation, invitation, or recommendation to purchase any securities. No representation or warranty, express or implied, is made as to the fairness, accuracy, completeness, or correctness of the information, opinions, and conclusions contained in this document. To the maximum extent permitted by law, none of Quantius, its directors, employees, or agents, nor any other person accepts any liability, including without limitation, any liability arising out of fault or negligence for any loss arising from the use of the information contained in this communication. The information may contain forward-looking information relating to future events or performance and reflects the General Partner and the Manager’s expectations and assumptions, based on information currently available to the General Partner and/or the Manager. Future results may differ materially from past results of any investments. The risks, uncertainties and other factors that could influence future results are described in the Fund’s Offering Memorandum. Any investment in the Fund involves risk, including the loss of principal. Past performance is no guarantee of future results.